openPR Logo
Press release

myriamed has joined Science Exchange

03-17-2021 03:24 PM CET | Health & Medicine

Press release from: myriamed GmbH

myriamed has joined Science Exchange

myriamed has joined Science Exchange

Science Exchange, the leading SaaS-enabled marketplace platform for outsourced R&D services, has partnered with myriamed. Visit myriamed’s profile to inquire about our services or request a quote. There are no additional contracts required if you request on Science Exchange and you can order immediately.

Please visit our profile here: http://bit.ly/myriamed_Science_Exchange

About myriamed: myriamed has unique expertise in research and development of human induced pluripotent stem cells (iPSC), including genome edited lines, and in the controlling of their fate as to the differentiation into defined cellular lineages and tissues (published for example in Tiburcy et al. 2017 and Long et al. 2018). The myriamed product portfolio is constantly evolving and based on a comprehensive IP portfolio to offer its know-how and associated services in drug development.

About Science Exchange: Founded in 2011 in response to the global growth in R&D services, Science Exchange solves the challenges of outsourcing R&D by removing barriers in the outsourcing process – providing companies with instant access to a network of pre-qualified service providers, as well as contracting, project management and reporting tools. The Science Exchange platform increases scientists' access to innovation and improves productivity, freeing them up from the administrative tasks and delays associated with sourcing, establishing and managing service provider contracts. Additionally, the Science Exchange enterprise program enables organizations to consolidate R&D outsourcing spend into a single strategic relationship, driving efficiency and cost savings. Since 2011, Science Exchange has raised more than $70 million from Norwest Venture Partners, Maverick Ventures, Union Square Ventures, Collaborative Fund, Windham Ventures, OATV, the YC Continuity Fund, and others. Visit www.scienceexchange.com or connect via www.linkedin.com/company/science-exchange.

myriamed GmbH
Rudolf-Wissell-Str. 28a
37079 Göttingen
Tel.: +49 551 28878-170
Email: info@myriamed.com
Web: www.myriamed.com

myriamed – the drug development accelerator

Separating the pharmacological wheat from the chaff is the primary goal of myriamed. Our proprietary human cell and engineered tissue models allow for the simulation of health and disease in the dish. Our platform technologies find broad applications in early stages of drug discovery and refinement of the most promising therapeutic candidates.
The availability of human cell and tissue models is transforming preclinical drug development. Applications range from early stages of lead discovery to advanced individualized phenotypic screens to shape a promising therapeutic candidate. myriamed offers a broad portfolio of highly standardized services as well as custom-made solutions to accelerate drug development.
At myriamed we focus on heart and skeletal muscle as well as on neuronal organoids. Our myrCell and myrTissue platforms define wanted and unwanted drug effects in a unique human context. myrScreen combines our expertise in phenotypic drug screens and enables deep phenotyping of drug effects on healthy or diseased human heart and skeletal muscle as well as on neuronal organoids.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release myriamed has joined Science Exchange here

News-ID: 2257706 • Views: 283

More Releases from myriamed GmbH

myriamed is a member of the international 4D Bioprinting network
myriamed has become a member of the ZIM innovation network 4D Bioprinting. The network, which is led by EurA AG supports concrete innovative products and new services in the field of bioprinting for applications in biology, pharmacy, and medicine. Thus, the network promotes the commercialization of the innovative technologies of the network partners by market-oriented R&D projects and establishment of new value chains for biopharmaceuticals and medicine. Phase 1 of the
myriamed is now a member of the Network for Pharma Solutions
We are proud to announce that myriamed is now a member of the Network for Pharma Solutions (NetPhaSol). NetPhaSol is a cooperation network focusing on drug discovery & development. It serves as a platform for research, development and marketing of new products, technologies and services in drug development. About myriamed: myriamed has unique expertise in research and development of human induced pluripotent stem cells (iPSC), including genome edited lines, and in
Helping to accelerate the development of novel drugs against Covid-19 disease
Even though vaccines against Covid-19 will be available soon, artificial herd immunity via vaccination will probably not reached until the end of 2021. Thus, the current fight against Covid-19 disease heavily relies on already available drugs. Unfortunately, there is hardly any drug that fights the disease effectively. Cortisone based therapeutics are currently the ones used most frequently and most successfully. The originally promising drug Remdesivir, which has been approved for the
myriamed’s myrPlates are now also available from ZAGENO
We are proud to announce that myriamed’s myrPlates are now also available in the ZAGENO life science, e-commerce marketplace. myrPlates can be used for the generation of engineered human tissues. By parallel culture of up to 48 tissues in one myrPlate, e.g. contractile heart muscles or skeletal muscles can be obtained to serve numerous applications, such as drug screening and disease modelling. About myriamed: myriamed has unique expertise in research and development

All 5 Releases


More Releases for Science

Data Analytics & Science
Amvion Analytica would focus on BI for SMB’s. This is a conscious targeting strategy as Amvion feels its approach capture the exact struggle that prevents SMB’s to get into analyzing their data. Beyond skills, business opportunity to explore BI for SMB’s does look easier & profitable than focusing on large customers NO: 1, 2nd street, Dr. Ranga Road, Alwarpet Chennai- 600 018 Amvion Labs Pvt Ltd., started in 2016, by a team who
Tissue Science 2019
Tissue Science 2019 is the fundamental event that joins an unprecedented and worldwide authorities, experts and chiefs both from the academic network and industry from wherever all through the world to exchange their knowledge, capacity and research progressions in the field of Tissue Science and Regenerative Medicine. Tissue Science 2019 gives a general stage to sharing information and considerations, late frameworks in Regenerative medication, Tissue engineering, Organ regeneration and freshest
Plant Science Conference 2018
Meetings International proudly announces the Global Experts Meeting on International Conference on Plant Science scheduled on October 25-27, 2018 in Paris, France, with a theme of “Explore the Scope of Plant Science". Meetings International (Meetings Int.) is a global leader in producing high quality conferences, meetings, workshops and symposia in all major fields of science, technology and medicine. Since its inception, Meetings Int. has been associated with national and international associations,
Plant Science Conference 2018
Meetings International proudly announces the Global Experts Meeting on International Conference on Plant Science scheduled on October 25-27, 2018 in Paris, France, with a theme of “Explore the Scope of Plant Science". Meetings International (Meetings Int.) is a global leader in producing high quality conferences, meetings, workshops and symposia in all major fields of science, technology and medicine. Since its inception, Meetings Int. has been associated with national and international associations,
Bioelectronic Medicine: Science Fiction or Science Fact?
The resounding answer to the above question is, science fact! Bioelectronic Medicine is, and will continue to be, one of the fastest-growing industries, within the medical sector. BAC Medical Marketing has positioned itself perfectly to take full advantage of the rapid growth of Bioelectronic Medicine by offering a state-of-the-art device, and accompanying software, that has been used successfully by doctors on their patients throughout Europe and Asia for many years,
Science Gone Wrong: Welteislehre
What we classify as science is determined by the times we live in. That has been shown by a project of the Austrian Science Fund FWF on the phenomenon of Welteislehre (the Cosmic Ice Theory). At the start of the 20th century, a broad swathe of the general public believed in this now discredited theory of what the universe is made of and how it was created. The findings of